Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
New study reveals how fatty diet can lead to serious form of liver disease

New study reveals how fatty diet can lead to serious form of liver disease

Hep C and drug abuse often go hand in hand, but screening for infection lags

Hep C and drug abuse often go hand in hand, but screening for infection lags

Green leafy vegetables may reduce risk of developing liver steatosis

Green leafy vegetables may reduce risk of developing liver steatosis

Study finds new strains of hepatitis C virus in sub-Saharan Africa

Study finds new strains of hepatitis C virus in sub-Saharan Africa

Excess weight responsible for cancers globally finds report

Excess weight responsible for cancers globally finds report

New drug shows promise in treating sarcomas

New drug shows promise in treating sarcomas

Disrupted biological clock can contribute to onset of diseases, USC study shows

Disrupted biological clock can contribute to onset of diseases, USC study shows

Scientists reveal how DNA damage leads to cancer and hereditary diseases

Scientists reveal how DNA damage leads to cancer and hereditary diseases

Merck declares 2018 Life Science Award winners

Merck declares 2018 Life Science Award winners

Towards finding a druggable cancer target

Towards finding a druggable cancer target

New report highlights key focus areas to help cancer screening realize its full potential

New report highlights key focus areas to help cancer screening realize its full potential

Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway

Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway

Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis

Researchers find metabolite shuttle between cells in the liver that may combat tissue fibrosis

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Targeted radiation provides treatment option for children with hard-to-treat liver cancer

Circadian clock could play key role in the fight against liver cancer

Circadian clock could play key role in the fight against liver cancer

Study could provide novel treatment strategy for potentially blinding problem

Study could provide novel treatment strategy for potentially blinding problem

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Cytokine levels could predict autoimmune reactions to cancer immunotherapy

Study offers hope of early detection, treatment of liver cancer

Study offers hope of early detection, treatment of liver cancer

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

LKSOM and Hunter jointly receive $13.5 million grant from National Cancer Institute

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.